Pagonabarraga, J.; Arbelo, J.M.; Grandas, F.; Luquin, M.-R.; Martínez Martín, P.; Rodríguez-Oroz, M.C.; Valldeoriola, F.; Kulisevsky, J.
A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sci. 2020, 10, 176.
https://doi.org/10.3390/brainsci10030176
AMA Style
Pagonabarraga J, Arbelo JM, Grandas F, Luquin M-R, Martínez Martín P, Rodríguez-Oroz MC, Valldeoriola F, Kulisevsky J.
A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sciences. 2020; 10(3):176.
https://doi.org/10.3390/brainsci10030176
Chicago/Turabian Style
Pagonabarraga, Javier, José Matías Arbelo, Francisco Grandas, Maria-Rosario Luquin, Pablo Martínez Martín, Mari Cruz Rodríguez-Oroz, Francesc Valldeoriola, and Jaime Kulisevsky.
2020. "A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice" Brain Sciences 10, no. 3: 176.
https://doi.org/10.3390/brainsci10030176
APA Style
Pagonabarraga, J., Arbelo, J. M., Grandas, F., Luquin, M.-R., Martínez Martín, P., Rodríguez-Oroz, M. C., Valldeoriola, F., & Kulisevsky, J.
(2020). A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sciences, 10(3), 176.
https://doi.org/10.3390/brainsci10030176